Skip to main content

Blogs

eye%20exa.jpg (keep)

My Take on New Ocular Screening Guidelines for Plaquenil

A recent article published by the American Academy of Ophthalmology presented new recommendations for screening of patients being managed with hydroxychloroquine that changed the previous monitoring paradigm. More importantly, it has repositioned hydroxychloroquine from one of the safest medications that rheumatologists use to a drug that can have potentially significant ocular morbidity (if used in doses greater than 5 mg per kilogram and or for prolonged periods of time).

The Role of Hydroxychloroquine Blood Levels in SLE

We review the available literature, with a particular focus on the recent findings in the Hopkins Lupus Cohort, regarding the clinical utility of hydroxychloroquine blood levels in helping to clarify some of the issues regarding retinopathy, how best to dose this medication, and medication adherence. 

5 Things To Know About Antimalarials for Lupus (Best of 2015: #5)

Here are five things every rheumatologist should know about antimalarial medications for lupus. 

5 Things To Know About Antimalarials for Lupus

Here are five things every rheumatologist should know about antimalarial medications for lupus. 

across%20table.jpg

Across the Table: Cush & Schwartzman on Uveitis

In this edition of “Across the Table”, Drs. Cush and Schwartman discuss uveitis. Our expert, Dr. Sergio Schwartzman offers up his approach to diagnosis and management.

×